Allurion Technologies, Inc. (ALUR) vs PAVmed Inc. (PAVM)

Allurion Technologies, Inc. and PAVmed Inc. are both Medical Devices companies. PAVmed Inc. is the larger, with a market value of $19.4M against $16.7M — 1.2× the size. Allurion Technologies, Inc. grew revenue faster over the last twelve months: −55.5% against −89.0%. Allurion Technologies, Inc. has the higher net margin (−264.7% vs −18,417.9%) and the higher return on invested capital (0.00% vs −54.5%). Across the 16 metrics below, Allurion Technologies, Inc. leads on 11 and PAVmed Inc. on 5.

Valuation

Metric ALUR PAVM Medical Devices median
P/E n/m n/m 23.22
P/S 0.03 134.90 2.34
P/B n/m 0.98 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 5.28 235.94 2.24
Earnings yield (12,360.81%) (665.92%) (10.09%)
Free cash flow yield (5,453.16%) (49.19%) (8.47%)

Profitability

Metric ALUR PAVM Medical Devices median
Gross margin 52.70% (221.43%) 56.01%
Operating margin (211.21%) (23,841.07%) (15.03%)
Net margin (264.74%) (18,417.86%) (20.40%)
Free cash flow margin (180.19%) (6,948.21%) (7.24%)
Return on equity 45.16% (216.61%) (15.32%)
Return on assets (127.26%) (49.05%) (19.72%)
Return on invested capital 0.00% (54.50%) (10.33%)

Growth

Metric ALUR PAVM Medical Devices median
Revenue growth (TTM) (55.49%) (89.02%) 8.80%
EPS growth (last fiscal year) (18.97%) (143.04%) 29.03%
Revenue growth, 5-year CAGR — — 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALUR PAVM Medical Devices median
Debt to equity 0.00 0.78 0.07
Current ratio 0.30 1.19 2.50
Net debt to EBITDA 0.19 0.07 0.49

Dividend

Metric ALUR PAVM Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric ALUR PAVM Medical Devices median
Market cap 16.70m 19.39m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack